Cargando…
Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial
INTRODUCTION: Obesity is a global health issue that impacts quality of life. A calorie-restricted diet with high-intensity consultation provided via the internet may be an effective way to lose weight. The objective of this study was to assess the effectiveness of a practitioner-guided, mobile inter...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785159/ https://www.ncbi.nlm.nih.gov/pubmed/35063952 http://dx.doi.org/10.1136/bmjopen-2020-048106 |
_version_ | 1784638904023908352 |
---|---|
author | Wang, Xi Wang, Suyuan Zhang, Chenghui Zhong, Lingyu Lerman, Lilach Lerman, Amir Guo, Yanhong Wu, Yunhong Lopez-Jimenez, Francisco |
author_facet | Wang, Xi Wang, Suyuan Zhang, Chenghui Zhong, Lingyu Lerman, Lilach Lerman, Amir Guo, Yanhong Wu, Yunhong Lopez-Jimenez, Francisco |
author_sort | Wang, Xi |
collection | PubMed |
description | INTRODUCTION: Obesity is a global health issue that impacts quality of life. A calorie-restricted diet with high-intensity consultation provided via the internet may be an effective way to lose weight. The objective of this study was to assess the effectiveness of a practitioner-guided, mobile internet-based low-energy dietary intervention in overweight and obese populations in China. METHODS AND ANALYSIS: This open-label randomised controlled trial enrolled 220 overweight and obese adults aged 18–70 years who met the inclusion criteria. Participants were assigned to the control group (n=110) or trial group (n=110). The trial group will be enrolled in the MetaWell programme, a weight loss programme using diet replacement products, wireless scales and a mobile phone app. Participants in the control group will receive paper material containing a sample diet for weight loss. The follow-up period will be 1 year, and measurements will occur at 3, 6 and 12 months. Dual-emission X-ray absorptiometry and abdominal quantitative CT will be performed to estimate the percentage of overall body fat and areas of visceral and subcutaneous fat, alongside several cardiometabolic measurements. The primary outcome of this study is the change in body mas index (BMI) at 6 months after enrolment. A mixed-effects model will be used to compare BMI and body fat changes between the two groups. ETHICS AND DISSEMINATION: This study was approved by the ethics committee of the Hospital of Chengdu Office of the People’s Government of the Tibetan Autonomous Region. Advertisements for recruitment will be sent via official accounts using WeChat. The results will be disseminated via publications in academic journals and our clinic. Our study group will maintain contact with the participants to inform them of the study findings. TRIAL REGISTRATION NUMBER: ChiCTR1900021630. |
format | Online Article Text |
id | pubmed-8785159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87851592022-02-04 Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial Wang, Xi Wang, Suyuan Zhang, Chenghui Zhong, Lingyu Lerman, Lilach Lerman, Amir Guo, Yanhong Wu, Yunhong Lopez-Jimenez, Francisco BMJ Open Health Services Research INTRODUCTION: Obesity is a global health issue that impacts quality of life. A calorie-restricted diet with high-intensity consultation provided via the internet may be an effective way to lose weight. The objective of this study was to assess the effectiveness of a practitioner-guided, mobile internet-based low-energy dietary intervention in overweight and obese populations in China. METHODS AND ANALYSIS: This open-label randomised controlled trial enrolled 220 overweight and obese adults aged 18–70 years who met the inclusion criteria. Participants were assigned to the control group (n=110) or trial group (n=110). The trial group will be enrolled in the MetaWell programme, a weight loss programme using diet replacement products, wireless scales and a mobile phone app. Participants in the control group will receive paper material containing a sample diet for weight loss. The follow-up period will be 1 year, and measurements will occur at 3, 6 and 12 months. Dual-emission X-ray absorptiometry and abdominal quantitative CT will be performed to estimate the percentage of overall body fat and areas of visceral and subcutaneous fat, alongside several cardiometabolic measurements. The primary outcome of this study is the change in body mas index (BMI) at 6 months after enrolment. A mixed-effects model will be used to compare BMI and body fat changes between the two groups. ETHICS AND DISSEMINATION: This study was approved by the ethics committee of the Hospital of Chengdu Office of the People’s Government of the Tibetan Autonomous Region. Advertisements for recruitment will be sent via official accounts using WeChat. The results will be disseminated via publications in academic journals and our clinic. Our study group will maintain contact with the participants to inform them of the study findings. TRIAL REGISTRATION NUMBER: ChiCTR1900021630. BMJ Publishing Group 2022-01-21 /pmc/articles/PMC8785159/ /pubmed/35063952 http://dx.doi.org/10.1136/bmjopen-2020-048106 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Health Services Research Wang, Xi Wang, Suyuan Zhang, Chenghui Zhong, Lingyu Lerman, Lilach Lerman, Amir Guo, Yanhong Wu, Yunhong Lopez-Jimenez, Francisco Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial |
title | Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial |
title_full | Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial |
title_fullStr | Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial |
title_full_unstemmed | Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial |
title_short | Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial |
title_sort | internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in china: protocol for a randomised controlled trial |
topic | Health Services Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785159/ https://www.ncbi.nlm.nih.gov/pubmed/35063952 http://dx.doi.org/10.1136/bmjopen-2020-048106 |
work_keys_str_mv | AT wangxi internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial AT wangsuyuan internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial AT zhangchenghui internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial AT zhonglingyu internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial AT lermanlilach internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial AT lermanamir internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial AT guoyanhong internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial AT wuyunhong internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial AT lopezjimenezfrancisco internetbasedplatformforalowcaloriedietaryinterventioninvolvingprepackagedfoodforweightlossinoverweightandobeseindividualsinchinaprotocolforarandomisedcontrolledtrial |